Repurposed Antidepressant Shows Early Promise in COVID-19
The antidepressant fluvoxamine may help prevent serious respiratory problems when administered early in the course of COVID-19, results of a randomized, placebo-controlled trial show.
Related Articles
Getting Patients With Opioid Use Disorder Started on Buprenorphine in Primary Care
Former obstacles are no longer an issue to prescribing the drug.
Semaglutide Improves Knee Osteoarthritis Pain, Physical Function in Phase 3 Trial
Results of the STEP 9 study in people with knee OA and obesity show that semaglutide not only induced significant weight loss but also improved…
New Screening Protocol May Improve Prostate Cancer Detection
However, it’s not yet clear whether a new three-phase screening intervention, which incorporates PSA test, a four-kallikrein panel, and MRI, will reduce prostate cancer mortality.
Generalised Anxiety and Panic Disorder, Adults: Management
Covering the care and treatment of people aged 18 years and over with generalised anxiety disorder or panic disorder
Has Immunotherapy Found Its Place in Pancreatic Cancer?
A new study suggested that adding nivolumab to neoadjuvant treatment improves outcomes in patients with borderline resectable pancreatic cancer.
The Patient Knows Best: PROs in RA Practice and Research
Advanced systems for measuring patient-reported outcomes can help improve care of patients with rheumatoid arthritis and inform clinical research.
Deciding When to Use Immunosuppression for IgA Nephropathy
Dr Andrew Bomback of Columbia University discusses the most common question he gets about treating IgA nephropathy: when to treat with immunosuppressants.
Gastro-oesophageal Reflux Disease, Children
A useful guideline summary on the recognition, diagnosis, and management of GORD in children and young people
Allergy, Food in Under 19s: Assessment and Management
A clear and concise NICE guideline summary on the diagnosis and management of IgE-mediated and non-IgE-mediated food allergy in children and young people
Fever, Under 5s: Assessment and Management
A summary of the 2021 updated NICE guideline on fever in under 5s, with a ‘traffic light’ approach to assessing risk and features of specific…